Khivsara Archish, Raj Jeffrey Pradeep, Hegde Divya, Rao Mangala
Department of Psychiatry, St. John's Medical College, Bengaluru, Karnataka, India.
Department of Pharmacology, St. John's Medical College, Bengaluru, Karnataka, India.
Indian J Pharmacol. 2017 May-Jun;49(3):254-256. doi: 10.4103/ijp.IJP_414_16.
Idiosyncratic drug-induced liver injury (DILI) is damage to liver occurring at recommended dose of a drug in contrast to toxic or predictable DILI. Although it is common in first-generation antiepileptic drugs (AEDs), it is rare in newer AEDs such as topiramate. Topiramate commonly causes neurological adverse effects such as psychomotor slowing and somnolence. Hepatotoxicity by topiramate is rare and has been previously reported in combination with other drugs such as valproate and carbamazepine. Here, we report a case of topiramate-induced asymptomatic elevation of liver enzymes in an adult man diagnosed with alcohol dependence syndrome and alcohol withdrawal complicated with seizures.
特异质性药物性肝损伤(DILI)是指在药物推荐剂量下发生的肝脏损伤,这与中毒性或可预测的DILI不同。虽然它在第一代抗癫痫药物(AEDs)中很常见,但在新型AEDs如托吡酯中很少见。托吡酯通常会引起神经方面的不良反应,如精神运动迟缓及嗜睡。托吡酯引起的肝毒性很罕见,此前曾有与丙戊酸盐和卡马西平等其他药物联合使用时发生肝毒性的报道。在此,我们报告一例被诊断为酒精依赖综合征且酒精戒断并发癫痫的成年男性,其出现了托吡酯诱发的无症状肝酶升高的病例。